
52.55 Delayed Data As of Aug 15 | ![]() Today’s Change | 28.45 Today|||52-Week Range 66.00 | +0.40% Year-to-Date |
The 13 analysts offering 12-month price forecasts for Intra-Cellular Therapies Inc have a median target of 70.00, with a high estimate of 90.00 and a low estimate of 57.00. The median estimate represents a +33.21% increase from the last price of 52.55.
The current consensus among 14 polled investment analysts is to Buy stock in Intra-Cellular Therapies Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.